Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
8.99
-0.07 (-0.77%)
At close: Dec 31, 2025, 4:00 PM EST
9.03
+0.04 (0.44%)
After-hours: Dec 31, 2025, 7:58 PM EST
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $1.04 billion as of December 31, 2025. Its market cap has decreased by -20.74% in one year.
Market Cap
1.04B
Enterprise Value
469.42M
1-Year Change
-20.74%
Ranking
Category
Stock Price
$8.99
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $1.04B, an increase of 37.47%. That is a compound annual growth rate of 3.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.04B | -12.32% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |